Investment and Fundraising in FemTech in 2022 (Background).png

CONFERENCE  | 01 SEPTEMBER 2022 | 5 PM GMT+1

Investment and Fundraising
in FemTech in 2022

Join us for an interactive event about
the latest FemTech trends

ABOUT OUR CONFERENCE

The newly emerging FemTech market has developed into a robust ecosystem of start-ups and tech companies that create products to address women's healthcare needs. In recent years, there has been a surge in investment in FemTech companies, reaching $16 billion in July 2022 (+15% compared to December 2021).

FemTech Analytics is excited to welcome you back to our next online conference: ‘Investment and Fundraising in FemTech in 2022’ on 1st September 2022 at 5pm GMT+1, which will bring together leaders, founders, visionaries, organisations, and start-ups who all play a crucial role in solving complex questions in the FemTech Industry. 

A new report by FemTech Analytics will also be released: ‘FemTech Industry Landscape Q2 2022’. The report contains advanced analytics on the global FemTech sector, a look at next-generation technologies adopted by FemTech companies, and a look at projects in the sector.

The event will discuss: 

  • Mission-Driven Investment in Women’s Health

  • Investing in FemTech: Why do it?

  • Raising Capital in FemTech: Investors Perspective 2022

  • Raising Capital in FemTech: Opportunities & Challenges 2022

  • Strategies and Innovations in FemTech 

  • Current State of FemTech 2022

Don't miss out on your chance to attend: register today

DSC_9640.jpg

Ksenia Tugay

FemTech enthusiast and PhenomX Health Advisor

Dr. Ksenia Tugay holds PhD in Life Sciences from the University of Lausanne, Switzerland. She has 6 years of experience in management of Innovation Programs across different industries and solid business background. Ksenia is an advisor to a Swiss FemTech startup PhenomX Health and she is also working as an innovation expert for a leading health Swiss Insurance. Ksenia is passionate about innovation, entrepreneurship and women’s health. She is also a strong advocate of Future’s Thinking and believes that disruptive technologies combined with shared economy, empathy and collaboration are the key to ending existing inequalities in healthcare.

Kate B.png

Kate Batz

Director of FemTech Analytics and Managing Partner of Longevity.Capital 

Kate Batz, based in San Francisco, Head of US activities, is licensed to practice law in California and New York. A lawyer with 15+ years experience as a corporate attorney.

Bethany-Corbin-Headshots-7.jpg

Bethany Corbin

Femtech Practice Lead & Senior Counsel at Nixon Gwilt Law

Bethany Corbin, Senior Counsel and Femtech Practice Lead at Nixon Gwilt Law, empowers pioneering femtech and healthcare innovation companies to achieve their goals with well-crafted legal counsel and strategic guidance. She partners with emerging digital health companies at the forefront of healthcare transformation to ensure they are building robust, scalable, and legally compliant companies ready to lead the industry. As part of her role, Bethany helps femtech companies navigate the fundraising landscape, including the unique challenges that arise for female founders, and helps clients negotiate contracts with investors. Bethany's strategic guidance and insights have been featured in top news outlets and publications, including Forbes, Fortune, VICE, Teen Vogue, BBC, NPR, and more! Bethany is also the host of the Legally Femtech Podcast.

1659631658138.jpeg

Nelli Morgulchik

Venture Development Associate at Pioneer Group

Nelli is a Venture Development Associate at a life sciences venture builder, investor and operator, Pioneer Group.
Nelli was previously a Strategy Associate at Hertility, an award-winning early-stage women’s health start-up, formulating a B2B sales strategy and supporting next-round fundraising. She also worked in healthcare consulting, advising pharmaceutical and biotech companies on global and regional commercial strategy, and in biotech venture capital.  
Nelli holds a Master’s in Drug Discovery and Development from Imperial College Landon and a Bachelor’s in Natural Sciences from the University of Cambridge

Isabella_Grandic_Photo.JPG

Isabella Grandic

Co-Founder of Boob Blurb

Isabella Grandic co-founded Boob Blurb, a women's health conversation starter card game. Boob Blurb aims to break down the taboos associated with female bodies and to celebrate inquiry around our bodies. Formerly she worked on the project End Maternal Mortality (EMM) whose materials were donated to the Jigawan State Government in Nigeria to reduce deaths from postpartum hemorrhaging. In 2020 Isabella designed a standard framework for the British Standards Institute to evaluate health technology for women’s health. She studies biochemistry at the University of North Carolina under the Morehead-Cain scholarship. Her passionate hobby is writing on her blog, especially about philosophy, women’s equity and scientific progress

Headshot.png

Elissa Baker

Managing Partner at Phase2 Health

Elissa is a Managing Partner at Phase2 Health, where she manages go-to-market strategy for Phase2 Health's clients and oversees operations and marketing for Phase2 Health. As an RN, BSN, former neonatal nurse, published author of clinical research, and proven healthcare leader, she's made a career bringing digital health initiatives to market. With 10-years of healthcare, digital health sales, and marketing experience, Elissa has reviewed effective Public Relations and Account-Based Marketing strategies that get the attention of healthcare decision-makers and investors.

Alara Headshot.jpeg

Alara Akcasiz

Founder of Triwi Technologies

I work on business development, marketing, and product management of wellness & wearable products. I build communities for both product and service startups by creating engaging content for social media and various platforms. Meet me at the conference to hear about my story of crowdfunding for my Femtech startup!

proof-4714 copy.jpg

Rachel Bartholomew

Founder & CEO at Hyivy Health

Rachel Bartholomew is a 2 time entrepreneur who is now working on her second company, Hyivy Health, created after her recent fight with cervical cancer. Hyivy Health is creating a pelvic rehabilitation device for the 1 in 3 women worldwide who will experience a pelvic health complication in their lifetime. Rachel is a graduate of the University of Waterloo and has been working in various roles in the entrepreneurship ecosystem for over 10 years.

Rachel Braun Scherl--2_edited.jpg

Rachel Braun Scherl

Managing Partner, Business Builder, Marketing Strategist, Vagipreneurâ , SPARK Solutions for Growth ////  

Rachel Braun Scherl has a long track record of success as a growth strategist, marketing expert, Vagipreneur™ and public speaker. Over her 25+ year career, Rachel has grown some of the world’s leading brands and businesses as well as helped many start-ups achieve market dominance, with a specialty in female health and wellness. As Managing Partner of SPARK Solutions for Growth, Rachel counsels a global client base including Johnson & Johnson, Allergan, Pfizer and Bayer. In addition, Rachel serves as a key partner for many female health start-ups in reproductive health, pregnancy, birth control, and arousal among others.  

Rachel was Co-Founder and President of Semprae Laboratories, Inc., a venture-backed company focused on developing and marketing women's sexual health products. The company was sold to Innovus Pharmaceuticals, Inc. in 2013.  Rachel focuses on driving growth for female health and wellness companies.  In addition, she speaks broadly on entrepreneurship, leadership and women in business and is a monthly contributor to Huffington Post and a frequent contributor to Inc.  She earned her BA from Duke University, magna cum laude and Phi Beta Kappa and her MBA from Stanford University Graduate School of Business. Rachel is the recipient of numerous business awards.

MS Headshot - Color- High Res (1)_edited.jpg

Maryanna Saenko

Co-Founder and Partner at Future Ventures

Maryanna Saenko is an early-stage venture capitalist and co-founder of Future Ventures, early investors in SpaceX, Tesla, Neuralink, Planet, and Skype, which represent $800 billion of aggregate value creation. She invests in frontier technologies that make the world a better place, including nuclear fusion, sustainable agricultural and land management, bee immunology, and land restoration. She has held stints at Khosla Ventures, DFJ, and Airbus Ventures. She’s worked on lunar rovers, martian landers, driverless cars, and long-range low-frequency communication systems. Sample Speaking: TEDxCornell | Bloomberg Quicktake |Full Ratchet 

waiting-room-with-monitors.jpg

Investment and Fundraising in FemTech

01 SEPTEMBER 2022 | 5 PM GMT+1

Previous Events

The Rise of Advanced Technologies in the Pharmaceutical Industry (Facebook).png

"Raising Capital in FemTech: Opportunities and Challenges" is a free virtual event combining speaker's talks and the roundtable discussion on crucial investments topics. The lack of investments is a fundamental challenge for FemTech companies.

 

Investors and FemTech founders will share their insights and best practices, and answer all your questions about raising capital in the space.

Femtech Conference 1920x1080.png

“FemTech Advancing Women's Wellness and Lifespan” was a virtual 1-day conference featuring a number of FemTech influencers, including founders & CEOs of startups and established companies, investors, scientists and other key players in the Women's Health industry.


The event was focus on the impact of technologies on women’s health and lifespan and how FemTech contributes to women’s Longevity in general.

Femtech Conference 1920x1080 (1)-min.png

The virtual conference "FemTech Industry Landscape 2021: Discovering New Horizons" held on July 29, 2021, where professionals from FemTech Analytics and invited guest speakers who are Founders & CEO of FemTech companies and start-ups, Healthcare Innovators, Investors and Hubs, Women Influencers and Enthusiasts shared insights, findings and personal experience about new possibilities and cutting-edge technologies in fast developing FemTech market.